# Huacheng Venture Capital

> Huacheng Venture Capital is a VC fund in Guangzhou backing Health Care and Sales. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Guangzhou, China
- Total investments: 6
- Last investment: Feb 2026
- Lead investor: 17%
- Last updated: Aug 2026

Huacheng Venture Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 33% |
| Sales | 1 | 17% |
| EdTech | 1 | 17% |
| Energy | 1 | 17% |
| Nuclear | 1 | 17% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 50% |
| Seed | 1 | 17% |
| Series F | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aurora Starcom | Aurora Starcom is a national high-tech company specialising in the research and development of space laser communication technology. | $43.2M | Series A | Feb 06, 2026 |  |
| Startorus Fusion | Startorus Fusion focuses on developing and commercializing fusion energy technologies, aiming for controllable device miniaturization, commercialization, and fast iteration, integrating design, R&D, operation, and maintenance. |  | Seed | Mar 25, 2024 |  |
| EPICMEMS | Kaiyuan Communication Technology (Xiamen) Co., Ltd. is an local chip company focusing on RF front-end solutions. The company is headquartered in Haicang District, Xiamen City, and currently has an operation center in Zhangjiang, Shanghai, and sales and customer support centers in Shenzhen, Xi'an and Beijing. |  | Venture - Series Unknown | Dec 15, 2022 |  |
| Hopstem | Hopstem is a Hangzhou-based pharmaceutical company, engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering. |  | Series A | May 27, 2021 |  |
| Shun Taimai bud Group | Shun Taimai bud Group engages in the beer and malt production business. |  | Series F | Feb 24, 2020 |  |
| DMAI | We all have an innate thirst for knowledge and self-discovery. Yet we learn and consume information in vastly different ways. We crave information that we can digest and solutions that we believe will improve our lives. We find joy in learning when it makes an authentic connection to our individual interests. Even the most complex subjects arewithin our grasp when we’re motivated to master them and given rich feedback.DMAI's vision is to lift humanity by developing cognitive AI assistants and platforms that make personal connections to individuals. We seek to explore the dark matter of intelligence - the 95% “invisible” (i.e., functionality, physics, intent, causality, and human utility, through top-down inference and reasoning) that helps us understand the "visible" 5% we see with our sensory inputs.Where others build standardized methods, we seek to create personalized ones.Some stats that motivate us include: - Only 30% of Americans have a college degree. - Only 66% of non-native English speakers graduate high school. - 45% of Americans are living with a chronic health problem. - 68% of Americans don’t feel engaged in their jobs.We at DMAI believe cognitive AI and personalized learning platforms can give people the motivation to advance their lives while empowering teachers and healthcare professionals to provide more personalized instruction and care. | $70.9M | Series A | Jan 28, 2020 |  |

6 of 6 investments shown.

## Co-investors
- [SFUND](https://shizune.co/investors/profile/sfund) — VC Fund, 2 deals together
- [Beijing Information Industry Development Investment Fund](https://shizune.co/investors/profile/beijing-information-industry-development-investment-fund) — VC Fund, 1 deal together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- [Canton Venture Capital](https://shizune.co/investors/profile/canton-venture-capital) — VC Fund, 1 deal together
- [CAS Star](https://shizune.co/investors/profile/cas-star) — VC Fund, 1 deal together
- [CF Capital](https://shizune.co/investors/profile/cf-capital-5993) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Huacheng Venture Capital invest in?

Huacheng Venture Capital invests primarily in Health Care, Sales and EdTech startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Huacheng Venture Capital last invest?

The most recent investment recorded for Huacheng Venture Capital closed in Feb 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co